Trial Profile
A phase II study of biweekly pemetrexed and gemcitabine in patients with metastatic breast cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Jul 2006
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Pemetrexed (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 28 Jul 2006 Status change
- 27 Oct 2005 New trial record.